BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 21971457)

  • 1. Effects of hypoperfusion in Alzheimer's disease.
    Austin BP; Nair VA; Meier TB; Xu G; Rowley HA; Carlsson CM; Johnson SC; Prabhakaran V
    J Alzheimers Dis; 2011; 26 Suppl 3(Suppl 3):123-33. PubMed ID: 21971457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral blood flow measured by arterial spin labeling MRI as a preclinical marker of Alzheimer's disease.
    Wierenga CE; Hays CC; Zlatar ZZ
    J Alzheimers Dis; 2014; 42 Suppl 4(Suppl 4):S411-9. PubMed ID: 25159672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The identification and cognitive correlation of perfusion patterns measured with arterial spin labeling MRI in Alzheimer's disease.
    Meng M; Liu F; Ma Y; Qin W; Guo L; Peng S; Gordon ML; Wang Y; Zhang N
    Alzheimers Res Ther; 2023 Apr; 15(1):75. PubMed ID: 37038198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience.
    Johnson NA; Jahng GH; Weiner MW; Miller BL; Chui HC; Jagust WJ; Gorno-Tempini ML; Schuff N
    Radiology; 2005 Mar; 234(3):851-9. PubMed ID: 15734937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of Alzheimer's Disease from Frontotemporal Dementia and Mild Cognitive Impairment Based on Arterial Spin Labeling Magnetic Resonance Imaging: A Pilot Cross-Sectional Study from PUMCH Dementia Cohort.
    Mao C; You H; Hou B; Chu S; Jin W; Huang X; Shang L; Feng F; Peng B; Gao J
    J Alzheimers Dis; 2023; 93(2):509-519. PubMed ID: 37038812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pattern of cerebral hyperperfusion in Alzheimer's disease and amnestic mild cognitive impairment using voxel-based analysis of 3D arterial spin-labeling imaging: initial experience.
    Ding B; Ling HW; Zhang Y; Huang J; Zhang H; Wang T; Yan FH
    Clin Interv Aging; 2014; 9():493-500. PubMed ID: 24707173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum.
    Tosun D; Schuff N; Jagust W; Weiner MW;
    Neurodegener Dis; 2016; 16(1-2):87-94. PubMed ID: 26560336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early-stage differentiation between presenile Alzheimer's disease and frontotemporal dementia using arterial spin labeling MRI.
    Steketee RM; Bron EE; Meijboom R; Houston GC; Klein S; Mutsaerts HJ; Mendez Orellana CP; de Jong FJ; van Swieten JC; van der Lugt A; Smits M
    Eur Radiol; 2016 Jan; 26(1):244-53. PubMed ID: 26024845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer Disease and Mild Cognitive Impairment: Integrated Pulsed Arterial Spin-Labeling MRI and
    Riederer I; Bohn KP; Preibisch C; Wiedemann E; Zimmer C; Alexopoulos P; Förster S
    Radiology; 2018 Jul; 288(1):198-206. PubMed ID: 29762090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral Blood Flow Predicts Conversion of Mild Cognitive Impairment into Alzheimer's Disease and Cognitive Decline: An Arterial Spin Labeling Follow-up Study.
    Duan W; Zhou GD; Balachandrasekaran A; Bhumkar AB; Boraste PB; Becker JT; Kuller LH; Lopez OL; Gach HM; Dai W
    J Alzheimers Dis; 2021; 82(1):293-305. PubMed ID: 34024834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional cortical perfusion on arterial spin labeling MRI in dementia with Lewy bodies: Associations with clinical severity, glucose metabolism and tau PET.
    Nedelska Z; Senjem ML; Przybelski SA; Lesnick TG; Lowe VJ; Boeve BF; Arani A; Vemuri P; Graff-Radford J; Ferman TJ; Jones DT; Savica R; Knopman DS; Petersen RC; Jack CR; Kantarci K
    Neuroimage Clin; 2018; 19():939-947. PubMed ID: 30003031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral Blood Flow Is Associated with Diagnostic Class and Cognitive Decline in Alzheimer's Disease.
    Duan W; Sehrawat P; Balachandrasekaran A; Bhumkar AB; Boraste PB; Becker JT; Kuller LH; Lopez OL; Gach HM; Dai W
    J Alzheimers Dis; 2020; 76(3):1103-1120. PubMed ID: 32597803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoperfusion in frontotemporal dementia and Alzheimer disease by arterial spin labeling MRI.
    Du AT; Jahng GH; Hayasaka S; Kramer JH; Rosen HJ; Gorno-Tempini ML; Rankin KP; Miller BL; Weiner MW; Schuff N
    Neurology; 2006 Oct; 67(7):1215-20. PubMed ID: 17030755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microvascular perfusion based on arterial spin labeled perfusion MRI as a measure of vascular risk in Alzheimer's disease.
    Zhang Q; Stafford RB; Wang Z; Arnold SE; Wolk DA; Detre JA
    J Alzheimers Dis; 2012; 32(3):677-87. PubMed ID: 22886015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voxel-wise correlations between cognition and cerebral blood flow using arterial spin-labeled perfusion MRI in patients with Alzheimer's disease: a cross-sectional study.
    Kaneta T; Katsuse O; Hirano T; Ogawa M; Shihikura-Hino A; Yoshida K; Odawara T; Hirayasu Y; Inoue T
    BMC Neurol; 2017 May; 17(1):91. PubMed ID: 28506213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral blood flow is diminished in asymptomatic middle-aged adults with maternal history of Alzheimer's disease.
    Okonkwo OC; Xu G; Oh JM; Dowling NM; Carlsson CM; Gallagher CL; Birdsill AC; Palotti M; Wharton W; Hermann BP; LaRue A; Bendlin BB; Rowley HA; Asthana S; Sager MA; Johnson SC
    Cereb Cortex; 2014 Apr; 24(4):978-88. PubMed ID: 23236200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perfusion abnormalities in mild cognitive impairment and mild dementia in Alzheimer's disease measured by pulsed arterial spin labeling MRI.
    Alexopoulos P; Sorg C; Förschler A; Grimmer T; Skokou M; Wohlschläger A; Perneczky R; Zimmer C; Kurz A; Preibisch C
    Eur Arch Psychiatry Clin Neurosci; 2012 Feb; 262(1):69-77. PubMed ID: 21786091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional cerebral perfusion in patients with Alzheimer's disease and mild cognitive impairment: effect of APOE epsilon4 allele.
    Kim SM; Kim MJ; Rhee HY; Ryu CW; Kim EJ; Petersen ET; Jahng GH
    Neuroradiology; 2013 Jan; 55(1):25-34. PubMed ID: 22828738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral perfusion and glucose metabolism in Alzheimer's disease and frontotemporal dementia: two sides of the same coin?
    Verfaillie SC; Adriaanse SM; Binnewijzend MA; Benedictus MR; Ossenkoppele R; Wattjes MP; Pijnenburg YA; van der Flier WM; Lammertsma AA; Kuijer JP; Boellaard R; Scheltens P; van Berckel BN; Barkhof F
    Eur Radiol; 2015 Oct; 25(10):3050-9. PubMed ID: 25899416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different post label delay cerebral blood flow measurements in patients with Alzheimer's disease using 3D arterial spin labeling.
    Liu Y; Zeng X; Wang Z; Zhang N; Fan D; Yuan H
    Magn Reson Imaging; 2015 Nov; 33(9):1019-1025. PubMed ID: 26113261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.